Cargando…

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients

Previous studies have shown that hepatitis B core antibody (anti-HBc) levels vary during different phases of disease in treatment-naïve chronic hepatitis B (CHB) patients and can be used as a predictor of both interferon-α and nucleoside analogue therapy response. However, there is no information on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Min-Ran, Lu, Jian-Hua, Ye, Li-Hong, Sun, Xing-Li, Zheng, Yan-Hua, Liu, Zhi-Quan, Zhang, Hai-Cong, Liu, Yun-Yan, Lv, Ying, Huang, Yan, Dai, Er-Hei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400315/ https://www.ncbi.nlm.nih.gov/pubmed/27559949 http://dx.doi.org/10.1097/MD.0000000000004422

Ejemplares similares

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B
por: Li, Min-ran, et al.
Publicado: (2016)

Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B: A Prospective Observational Study
por: Jia, Wei, et al.
Publicado: (2014)

Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody
por: Lai, Ming-Wei, et al.
Publicado: (2016)

Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection
por: Li-Shuai, Qu, et al.
Publicado: (2017)

Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma
por: Jiang, Jiang, et al.
Publicado: (2017)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients
por: Asil, Mehmet, et al.
Publicado: (2016)

Expression and significance of urinary microRNA in patients with chronic hepatitis B
por: Shang, Jia-Wei, et al.
Publicado: (2019)

Mutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy
por: Geng, Yan, et al.
Publicado: (2016)

Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients
por: Ungtrakul, Teerapat, et al.
Publicado: (2017)

Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Hui-Hui, et al.
Publicado: (2020)

Increased A20 mRNA Level in Peripheral Blood Mononuclear Cells is Associated With Immune Phases of Patients With Chronic Hepatitis B
por: Sun, Yan-Yan, et al.
Publicado: (2015)

Establishment and Validation of ALPH-Q Score to Predict Mortality Risk in Patients With Acute-on-Chronic Hepatitis B Liver Failure: A Prospective Cohort Study
por: Wu, Sheng-Jie, et al.
Publicado: (2015)

The role of IL22 polymorphisms on liver cirrhosis in patients with hepatitis B virus: A case control study
por: Gao, Yan-Hang, et al.
Publicado: (2019)

Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women: A systematic review and meta-analysis
por: Chen, Zhe, et al.
Publicado: (2020)

Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B
por: Liu, Liang, et al.
Publicado: (2019)

Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: Transarterial Chemoembolization or Hepatic Resection?
por: Jianyong, Lei, et al.
Publicado: (2014)

The Plasma S-adenosylmethionine Level is Associated With the Severity of Hepatitis B-Related Liver Disease
por: Li, Ting, et al.
Publicado: (2015)

Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis: A Nationwide Population-Based Study
por: Chen, Chien-Hua, et al.
Publicado: (2015)

Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
por: Liu, Yanqiong, et al.
Publicado: (2015)

A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B
por: Zhang, Kang-Ling, et al.
Publicado: (2021)

Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
por: Wang, Lingmei, et al.
Publicado: (2020)

Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma
por: Ma, Qiang, et al.
Publicado: (2016)

Virological and serological features of acute hepatitis B in adults
por: Du, Xiaofei, et al.
Publicado: (2017)

Combination therapy based on pegylated interferon alfa improves the therapeutic response of patients with chronic hepatitis B who exhibit high levels of hepatitis B e-antigen at 24 weeks: A retrospective observational study
por: Zhang, Yafei, et al.
Publicado: (2019)

Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report
por: Liu, Yu, et al.
Publicado: (2022)

Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1
por: Zhu, Gui-Qi, et al.
Publicado: (2016)

Sofosbuvir and ribavirin in acute hepatitis C–infected patient with decompensated cirrhosis
por: Liu, Hui, et al.
Publicado: (2016)

Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
por: Lee, I-Cheng, et al.
Publicado: (2015)

Identification of key candidate genes and pathways in hepatitis B virus-associated acute liver failure by bioinformatical analysis
por: Lin, Huapeng, et al.
Publicado: (2018)

Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment
por: Yang, Jiezuan, et al.
Publicado: (2017)

Vitamin D serum level is associated with Child–Pugh score and metabolic enzyme imbalances, but not viral load in chronic hepatitis B patients
por: Zhao, Xin-yan, et al.
Publicado: (2016)

Effect of tenofovir on renal function in patients with chronic hepatitis B
por: Jung, Woo Jin, et al.
Publicado: (2018)

Dynamics of Genotypic Mutations of the Hepatitis B Virus Associated With Long-Term Entecavir Treatment Determined With Ultradeep Pyrosequencing: A Retrospective Observational Study
por: Zhang, Xia-Xia, et al.
Publicado: (2016)

The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease
por: Liang, Jing, et al.
Publicado: (2016)

Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study
por: Zhu, Yun-Feng, et al.
Publicado: (2019)

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database
por: Tsai, Pei-Chien, et al.
Publicado: (2017)

Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area
por: Hu, Jing-Hong, et al.
Publicado: (2016)

Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9g52rtr51nqjs4q4sh7j06h0sp